December 03, 2018
Sponsored by
SeraCare

Analytical Validation of Oncomine Breast cfDNA Assay v2

Partner Webinar

Join or Log in for Access

This content is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Oncomine Breast cfDNA Assay v2 is designed to detect mutations in 10 breast cancer-related genes including PIK3CA, AKT1, ESR1, TP53 and ERBB2 (~152 hotspots) and copy number variation in CCND1, ERBB2 and FGFR1. We performed analytical validation studies for the detection of hotspot mutations and copy number variation using commercially available cfDNA controls, full-length and fragmented cell line DNA dilutions, plasma-derived cfDNA samples and FFPE DNA samples.

Sponsored by

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.